Inhibition of angiogenesis by extracellular protein kinase A

Cancer Letters

Volumn 283, Issue 1, 2009, Pages 68-73

  Szkudlarek, Maria ^a   Bosio, Rual M ^a   Wu, Qiong ^a   Chin, Khew Voon ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Angiogenesis; Chorioallantoic; ECPKA; Extracellular; PKA

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; EXTRACELLUALR PROTEIN KINASE A; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHICK EMBRYO; CULTURE MEDIA, CONDITIONED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67650444293     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.03.027     Document Type: Article

References (21)

1. Taylor S.S., Kim C., Cheng C.Y., Brown S.H., Wu J., and Kannan N. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design. Biochim. Biophys. Acta 1784 (2008) 16-26
2. Burns-Hamuro L.L., Ma Y., Kammerer S., Reineke U., Self C., Cook C., Olson G.L., Cantor C.R., Braun A., and Taylor S.S. Designing isoform-specific peptide disruptors of protein kinase A localization. Proc. Natl. Acad. Sci. USA 100 (2003) 4072-4077
3. Cho Y.S., Park Y.G., Lee Y.N., Kim M.K., Bates S., Tan L., and Cho-Chung Y.S. Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression. Proc. Natl. Acad. Sci. USA 97 (2000) 835-840
4. Cvijic M.E., Kita T., Shih W., DiPaola R.S., and Chin K.V. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer. Clin. Cancer. Res. 6 (2000) 2309-2317
5. Cho Y.S., Lee Y.N., and Cho-Chung Y.S. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker. Biochem. Biophys. Res. Commun. 278 (2000) 679-684
6. Kita T., Goydos J., Reitman E., Ravatn R., Lin Y., Shih W.C., Kikuchi Y., and Chin K.V. Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma. Cancer Lett. 208 (2004) 187-191
7. Wang H., Li M., Lin W., Wang W., Zhang Z., Rayburn E.R., Lu J., Chen D., Yue X., Shen F., Jiang F., He J., Wei W., Zeng X., and Zhang R. Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 789-795
8. Nesterova M.V., Johnson N., Cheadle C., Bates S.E., Mani S., Stratakis C.A., Khan I.U., Gupta R.K., and Cho-Chung Y.S. Autoantibody cancer biomarker: extracellular protein kinase A. Cancer Res. 66 (2006) 8971-8974
9. Beebe S.J. The cAMP-dependent protein kinases and cAMP signal transduction. Semin Cancer Biol. 5 (1994) 285-294
10. Chin K.V., Yang W.L., Ravatn R., Kita T., Reitman E., Vettori D., Cvijic M.E., Shin M., and Iacono L. Reinventing the wheel of cyclic AMP: novel mechanisms of cAMP signaling. Ann. NY Acad. Sci. 968 (2002) 49-64
11. Ausprunk D.H., Knighton D.R., and Folkman J. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38 (1974) 237-248
12. Duffy M.J., McGowan P.M., and Gallagher W.M. Cancer invasion and metastasis: changing views. J. Pathol. 214 (2008) 283-293
13. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 580 (2006) 2879-2887
14. Richardson P., Hideshima T., and Anderson K. Thalidomide: emerging role in cancer medicine. Ann. Rev. Med. 53 (2002) 629-657
15. Dalton G.D., and Dewey W.L. Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function. Neuropeptides 40 (2006) 23-34
16. Hashimoto A., Miyakoda G., Hirose Y., and Mori T. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189 (2006) 350-357
17. Volpert O.V., Pili R., Sikder H.A., Nelius T., Zaichuk T., Morris C., Shiflett C.B., Devlin M.K., Conant K., and Alani R.M. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell 2 (2002) 473-483
18. Nishiyama K., Takaji K., Uchijima Y., Kurihara Y., Asano T., Yoshimura M., Ogawa H., and Kurihara H. Protein kinase A-regulated nucleocytoplasmic shuttling of Id1 during angiogenesis. J. Biol. Chem. 282 (2007) 17200-17209
19. Kim S., Bakre M., Yin H., and Varner J.A. Inhibition of endothelial cell survival and angiogenesis by protein kinase A. J. Clin. Invest. 110 (2002) 933-941
20. Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., and Stratton M.R. Patterns of somatic mutation in human cancer genomes. Nature 446 (2007) 153-158
21. Skalhegg B.S., and Tasken K. Specificity in the cAMP/PKA signaling pathway Differential expression regulation and subcellular localization of subunits of PKA. Front. Biosci. 5 (2000) D678-D693